100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human IGFBP-7 (Insulin Like Growth Factor Binding Protein 7) CLIA Kit (HUES00323)

SKU HUES00323
Product Type ELISA Kit
ELISA Type CLIA Kit
Size 96 Assays
Sensitivity 0.09ng/mL
Range 0.16-10ng/mL
ELISA Type Sandwich
Synonyms AGM, FSTL2, IBP-7, IGFBP-7, IGFBP-7v, IGFBPRP1, MAC25, PSF, RAMSVPS, TAF
Reactivity Human
Sample Type Serum, plasma and other biological fluids
Research Area Cell Biology
€769

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human IGFBP-7 (Insulin Like Growth Factor Binding Protein 7) CLIA Kit

The Human IGFBP-7 (Insulin-like Growth Factor Binding Protein 7) CLIA Kit is a powerful tool for detecting IGFBP-7 levels in human samples such as serum, plasma, and cell culture supernatants. With its high sensitivity and specificity, this kit provides accurate and reliable results for a variety of research purposes.IGFBP-7 is a key protein involved in regulating the activity of insulin-like growth factors and has been implicated in various diseases, including cancer, cardiovascular diseases, and metabolic disorders.

By measuring IGFBP-7 levels, researchers can gain insights into the mechanisms underlying these conditions and potentially identify new therapeutic targets.Overall, the Human IGFBP-7 CLIA Kit is essential for studying the role of IGFBP-7 in health and disease, providing valuable information for further research and the development of targeted treatments.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose